Market size, growth to 2033 and clinical trials, side by side.
Germany is the bigger Diabetes Care Devices market: $1.6 Bn against $1.1 Bn in 2023, about 1.4 times as large.
Germany grows faster: 4.1% a year, against 3.9%.
Clinical research: 42 active trials in the UK, 18 in Germany.
| Measure | ||
|---|---|---|
| Market size, 2023 | $1.1 Bn | $1.6 Bn |
| Market size, 2033 projected | $1.6 Bn | $2.3 Bn |
| Growth a year (CAGR) | 3.9% | 4.1% |
| Money added, 2023–2033 | $516 Mn | $771 Mn |
| Share of the world market | 2.6% | 3.7% |
| Size rank of 24 countries | #7 | #5 |
| Market per person, 2023 | $16 | $19 |
| Active clinical trials | 42 | 18 |
| Diabetes (adults) % of adults (WHO) | 8.8 2022 | 6.6 2022 |
| Full report | UK report | Germany report |
UK Germany · values between 2023 and 2033 are projected from the 2023 size and the CAGR.
Germany is the bigger Diabetes Care Devices market: $1.6 Bn against $1.1 Bn in 2023, about 1.4 times as large.
Germany grows faster: 4.1% a year, against 3.9%.
Sources: market size and growth: Acuitas Health Analytics research (2023 base year, forecasts to 2033). Trials: ClinicalTrials.gov (fetched 10 Nov 2026); found by search words, so counts are a guide. Health figures: WHO. Population: World Bank.